Oncofusion

start / graph / gene-utp18

Geneweak confidence 2 of 5: Preliminary, small, indirect, or not yet peer reviewed.Q88-nucleolar-block

UTP18 / WDR50 (Q9Y5J1) - the SSU processome subunit that recruits the exosome helicase MTREX to rRNA fragments; in three MLL-fusion interactomes but not the index fusion's, and separately the subject of a 21-year-old IntAct curation error in this graph

also called UTP18 · WDR50 · CGI-48 · U3 small nucleolar RNA-associated protein 18 homolog · WD repeat-containing protein 50

UTP18 helps cut ribosomal RNA into shape and then hands the leftover pieces to the machine that destroys them. It shows up in three of the seven MLL-fusion pulldowns - and separately, a public database has spent twenty-one years wrongly listing it as part of the MLL complex when the paper it cites actually reported WDR5.

The same thing, for a scientist

UTP18 (Q9Y5J1, 556 aa; sole gene synonym **WDR50**) is a WD-repeat SSU processome subunit with a second, sharper job: it is an **adaptor that recruits the exosome-associated helicase Mtr4 (human MTREX) to cleaved rRNA fragments destined for exosome degradation**, docking through a short consensus motif onto Mtr4's arch domain - the same motif used by Nop53/PICT1 to target pre-ribosomal particles [E2]. It is also reported gained and overexpressed in cancer, with a cytoplasmic pool that associates with the translation machinery and Hsp90 [E3]. Sub-nuclearly it is one of only three proteins in this entire block with a published human sub-compartment: GFP-UTP18, with TBL3 and PWP2, localises to the **dense fibrillar component and granular component** regions and relocates to nucleolar caps and bodies when rRNA transcription is suppressed [E4]. In Skucha 2018 UTP18 was recovered by three of seven MLL fusions - MLL-AF9, MLL-EEN and MLL-ENL - and is **absent from the MLL-AF4 column** and below the shRNA-library threshold [E1]. **This entry extends and does not contradict `ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated`**: that entry's finding - that IntAct's KMT2A-UTP18 row from PMID 15199122 is a WDR5 substitution - stands untouched, and is about a different experiment in a different paper [E5].

Go deeper
Two separate things called 'UTP18 in the MLL literature', and they must not be merged

This graph already holds ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated, which established that IntAct's KMT2A-UTP18 association attributed to PMID 15199122 (Yokoyama 2004, the founding menin/MLL-complex paper) is a curation error: the paper's own eight polypeptides include WDR5 and never mention UTP18, WDR50 or CGI-48, and IntAct's participant list is the paper's list with WDR5 replaced by UTP18. That entry's verdict was 'no entry written for UTP18 - the partner does not exist' 5.

That verdict was correct and remains correct, and it is about the IntAct row. It is not about the Skucha AP-MS dataset, which that entry does not cite and which measures something else entirely: a different paper, a different bait set, a different cell line, a different method.

So the record has two independent statements and this entry writes both:

  1. UTP18 is not a KMT2A partner from PMID 15199122. WDR5 is. The database row is wrong and should be reported to IntAct.
  2. UTP18 IS present in the Skucha 2018 MLL-fusion AP-MS network, recovered by three of seven fusion baits with a zero negative control - and NOT by MLL-AF4.

A reader who takes statement 1 as meaning 'UTP18 has nothing to do with MLL fusions' would be over-reading it, and a reader who takes statement 2 as rehabilitating the IntAct row would be over-reading that. The earlier entry is not edited by this beat; this is a cross-reference and a scoping note.

The exosome adaptor function, which is the most interesting thing in this block

The exosome processes, degrades and surveils an enormous range of RNA, and the question of how it finds its substrates was answered by identifying adaptor proteins that recruit the exosome-associated helicase Mtr4. Nop53 (the yeast homologue of the tumour suppressor PICT1) targets Mtr4 to pre-ribosomal particles for processing, and Utp18 recruits Mtr4 to cleaved rRNA fragments destined for degradation. Both dock through the same consensus motif onto Mtr4's arch domain 2.

This is worth flagging for one reason internal to this repo. The complex-level re-run of this interactome places NEXT/exosome at 9 of 17 subunits, q(BH) = 6.7e-08 - the fourth-ranked complex in the whole network, behind the nucleolar block, CCT/TRiC and the SEC. So this interactome contains both the nucleolar block and the exosome, and UTP18 is the documented physical bridge between them. That is a genuine structural observation about the network.

It is also, immediately, a warning. Two co-enriched complexes joined by a known adaptor is exactly the configuration in which a single real association drags in a large number of passengers - which is the mechanism by which an AP-MS experiment produces a coherent-looking but non-specific block. The observation supports the block's internal coherence and does nothing to establish fusion-specificity.

Sub-nuclear position - one of only three in the block that is actually published

Human GFP-UTP18, together with PWP2 and TBL3, localises to the dense fibrillar component and granular component regions of nucleoli - the UTP-B sub-complex distribution - and relocates to the cap and body regions when rRNA transcription is suppressed; mobility in living cells is very low, indicating a structurally immobilised rather than freely exchanging component 4.

Across the eleven proteins this beat wrote, that is a rare thing. Seven have no sub-nucleolar assignment at all (PA2G4, NOP2, TCOF1, RRP12, WDR18, UTP14A, RRP9 - each recorded as a bounded absence), LYAR's DFC call is an inference by similarity from mouse, GNL2's granular-component call is a GFP fusion in Drosophila, and only UTP18 has a published human sub-compartment - shared with TBL3, which already has an entry citing the same source. The nucleolar block's sub-nuclear resolution is far thinner than 'nucleolus' makes it sound, and that is a finding about the literature this beat was sent to test.

Facts and figures
uniprotQ9Y5J1
length AA556
accession resolutionResolved live 2026-09-21: gene_exact:UTP18 AND organism_id:9606 AND reviewed:true returns EXACTLY ONE reviewed row - Q9Y5J1, UTP18_HUMAN, gene_primary UTP18, sole synonym WDR50, 556 aa, protein name 'U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)'. This matches the accession and length recorded by ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated, independently re-fetched. THE COLLISION IS LIVE AND DOCUMENTED IN THIS GRAPH: WDR50 (this protein) against WDR5 (P61964, gene-wdr5, a WRAD subunit central to KMT2A biology), whose recommended names differ only by the number - 'WD repeat-containing protein 50' and 'WD repeat-containing protein 5'. That is rule 66's MLL2/MLL4 shape exactly, and it has already produced one twenty-one-year error in this literature. data/symbol-collisions.json checked per rule 88: NO ROW for UTP18, WDR50, WDR5 or CGI-48 - the collision is recorded in a graph analysis entry but NOT in the registry, which is a gap reported to the coordinator.
localizationNucleus, nucleolus (UniProt Q9Y5J1, ECO:0000269 citing PubMed 12429849 and 34516797; fetched 2026-09-21). A condition-dependent cytoplasmic pool is separately reported, increased by serum withdrawal and associated with the translation complex and Hsp90 (PMID 25435373).
subnuclear localizationNUCLEOLUS, and within it the DENSE FIBRILLAR COMPONENT and GRANULAR COMPONENT regions - the UTP-B sub-complex distribution - relocating to the nucleolar CAP and BODY regions when rRNA transcription is suppressed, with very low mobility in living cells (PMID 24754225, human GFP imaging and photobleaching). This is one of only THREE published sub-nucleolar assignments among the thirteen block members, and the only human one this beat added: the same source places TBL3 and PWP2 identically. Seven of this beat's eleven proteins have no sub-nucleolar assignment at all.
localization shown for fusionNO - nobody has imaged UTP18 in any KMT2A-rearranged cell, and the index fusion did not recover it.
shown for fusionMLL-AF9, MLL-EEN and MLL-ENL by co-purification in Jurkat. NOT MLL-AF4. Never functionally screened against any MLL fusion. NO independent experiment ties UTP18 to any KMT2A fusion - and the one database row that appeared to is an adjudicated curation error in which WDR5 was the protein actually reported.
selectivityUNKNOWN and untestable from this source - UTP18 never entered the shRNA screen. Not among the paper's named non-selectivity controls (RFC1, SF3A3, CCT3), which here means only that it was never a candidate. Independently: UTP18 is reported frequently gained and overexpressed across cancers, which is a pan-cancer growth profile rather than a selectivity signal. Not nominated as a target.
functional screenFUNCTIONAL SCREEN -- NOT SCREENED. The shRNA library (MOESM5) covers the 128 interactors shared by at least five of the seven baits: 768 rows, 128 symbols, exactly six shRNAs each, counted with openpyxl by this beat on 2026-09-21. This protein's symbol is NOT in that library, because it falls below the five-bait threshold. So unlike the seven-plus-bait members of this block it has never been functionally tested against any MLL fusion, even in the source paper. That is a stronger absence than measured-not-reported.
absence classnever-measured
absence class noteBelow the five-bait shRNA-library threshold, so UTP18's functional requirement in an MLL-fusion cell has never been measured by any instrument - never-measured, not measured-not-reported. Its binding relationship to the index fusion is likewise unmeasured rather than negative, since MLL-AF4 is the shallowest bait. PRIDE checked: PXD009338 is the only relevant deposition; re-searching its MLL-AF4 raw files addresses the binding half without wet work.
graph contextUTP18 was mentioned in 7 node files before this entry - the most of any of this beat's eleven - almost all of them concerning the IntAct miscuration rather than the protein. The dedicated entry ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated records that adjudication and explicitly declined to write a gene entry ('the partner does not exist'), scoped to the IntAct/PMID 15199122 row. THIS ENTRY EXTENDS THAT AND DOES NOT REVISE IT: the gene entry is written on the strength of the Skucha AP-MS data, which that entry does not cite, and the miscuration finding is left exactly as it stands. That entry was read in full before this one was written and was not edited.
correction reported not appliedTwo items outside this beat's file set, reported rather than edited. (1) The sibling entry's verdict string 'no entry written for UTP18 - the partner does not exist' is scoped to the IntAct row but is quotable as a claim about UTP18 in general, which the Skucha table contradicts at three of seven baits; a scoping clause would fix it. (2) data/symbol-collisions.json has NO row for the WDR5/WDR50 collision even though this graph holds a dedicated analysis entry about an error it caused - rule 88's registry is missing the one collision this corpus has actually been burned by.
skucha 2018
{
  "bait": "MLL-AF4 (= KMT2A::AFF1)",
  "in_the_index_bait_column": false,
  "p_value_mll_af4": null,
  "index_bait_note": "ABSENT from the MLL-AF4 column entirely - no p-value, no spectral count.",
  "n_fusions_of_seven": 3,
  "negative_control_spectra": 0,
  "baits_that_recovered_it": [
    "MLL-AF9",
    "MLL-EEN",
    "MLL-ENL"
  ],
  "baits_that_did_not": [
    "MLL-AF1p",
    "MLL-AF4",
    "MLL-CBP",
    "MLL-GAS7"
  ],
  "below_shrna_library_threshold": true,
  "relationship_to_the_intact_miscuration": "INDEPENDENT AND COMPATIBLE. Different paper (29777171 vs 15199122), different method (Strep-HA AP-MS vs anti-bait co-IP and molecular sieving), different cells (Jurkat vs K562), different bait (seven MLL fusion transgenes vs endogenous KMT2A). The miscuration verdict stands; this row does not rehabilitate it; and this row is not weakened by it.",
  "source": "n_fusions supplied pre-verified by the coordinator from the cached MOESM4 xlsx; per-bait membership independently reproduced by this beat 2026-09-21 by re-running analyses/mll-fusion-interactome-complexes/run.py. Library non-membership verified directly with openpyxl against the cached MOESM5 xlsx: 768 rows, 128 symbols, six shRNAs each, UTP18 absent."
}
complex membership
{
  "complex": "Nucleolar / ribosome biogenesis; SSU processome UTP-B; AND an arch-domain adaptor recruiting the exosome helicase Mtr4/MTREX to cleaved rRNA fragments - the documented physical bridge between the nucleolar block and the NEXT/exosome complex, which is the fourth-ranked complex in this same network at 9 of 17 subunits, q(BH) = 6.7e-08",
  "block_enrichment": "15 of 26 subunits present in the 960-protein network, 1.25 expected, hypergeometric p = 6.99e-14, q(BH) = 8.39e-13 - the top-ranked of twelve complexes tested, ahead of the CCT/TRiC negative control (q = 1.4e-09) and the SEC positive control (q = 1.5e-09). Re-run by this beat 2026-09-21.",
  "per_bait_subunits_of_26": {
    "MLL-AF1p": 8,
    "MLL-AF4": 7,
    "MLL-AF9": 12,
    "MLL-CBP": 10,
    "MLL-EEN": 12,
    "MLL-ENL": 11,
    "MLL-GAS7": 7
  },
  "index_bait_members": [
    "GNL2",
    "LYAR",
    "NOLC1",
    "NOP2",
    "PA2G4",
    "TBL3",
    "TCOF1"
  ],
  "members_ABSENT_from_the_index_bait_column": [
    "RRP12",
    "WDR18",
    "UTP14A",
    "RRP9",
    "UTP18",
    "FTSJ3",
    "FBL",
    "NOP58"
  ],
  "background_caveat": "The hypergeometric background is the ~20,000-protein proteome, not the ~4,600 proteins actually recovered before filtering, so q is an UPPER BOUND on significance and is loosest for a complex of abundant nuclear proteins."
}
cell types and states
[
  "Jurkat (human T-ALL) - AP-MS host, nuclear lysate; recovered by three baits but NOT by MLL-AF4",
  "NOT in the MOLM-13 shRNA screen - below the five-bait library threshold",
  "human cultured cells - GFP sub-nucleolar imaging (DFC and GC), photobleaching, actinomycin-D cap relocation",
  "human cancer cells - copy-number gain and overexpression, cytoplasmic pool on serum withdrawal, Hsp90 and translation-complex association",
  "yeast and in vitro - Mtr4 arch-domain adaptor function",
  "K562 (human CML) - ONLY as the host of the mis-curated IntAct row, which is a curation artefact and not a measurement about UTP18",
  "no leukaemia measurement of any kind; no B-lineage, no infant, no KMT2A::AFF1 cell"
]
bounded literature
{
  "query": "(UTP18[tiab] OR WDR50[tiab]) AND (KMT2A[tiab] OR MLL[tiab] OR \"MLL-AF4\"[tiab] OR \"MLL-AF9\"[tiab] OR \"t(4;11)\"[tiab])",
  "querytranslation": "\"UTP18\"[Title/Abstract] AND (\"KMT2A\"[Title/Abstract] OR \"MLL\"[Title/Abstract] OR \"MLL-AF4\"[Title/Abstract] OR \"MLL-AF9\"[Title/Abstract] OR \"t 4 11\"[Title/Abstract])",
  "count": 0,
  "date": "2026-09-21",
  "tool": "NCBI esearch db=pubmed",
  "names_tried": [
    "UTP18",
    "WDR50"
  ],
  "positive_control": "MEN1[tiab] AND the identical five-term KMT2A clause returns 85, through the same query shape.",
  "operand_control": "The bare gene operand is non-zero, so the instrument can return a one for this symbol.",
  "bound": "Titles and abstracts only; supporting figures and full texts NOT searched. The cytogenetic term is quoted and the querytranslation shows 't 4 11'[Title/Abstract] with no injected [UID] term, so rule 95 is satisfied. One [tiab] tag per term, so rule 94 is satisfied.",
  "note": "Zero records, consistent with the independent count recorded by ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated, which ran a wider clause including 'leukemia' and also got zero. Note that beat's observation that PubMed silently drops the WDR50 operand because it matches nothing - so WDR50 contributes no recall and the bound rests on UTP18 alone."
}
How this could bite us back
  • UTP18 is an SSU processome subunit and an exosome adaptor - two essential RNA-metabolism functions. Inhibition is ribosome-biogenesis inhibition with RNA-surveillance failure on top, in an infant.
  • It is reported frequently gained and overexpressed across cancers, which means any inhibitor's therapeutic index depends on a copy-number difference rather than on a fusion-specific mechanism, and no KMT2A-rearranged copy-number data are cited here.
  • The reputational bite-back is the real one: this protein's name has already produced a wrong entry in a public database that propagated into this project's own coverage arithmetic. Any future automated pull on UTP18 in the MLL literature will re-encounter that row, because it is still live.
Still open
  1. UTP18 bridges the two most enriched non-control complexes in this network - the nucleolar block and NEXT/exosome - through a documented Mtr4 arch-domain adaptor motif. Is the exosome's enrichment in this interactome a consequence of the nucleolar block's, or are they independent? The per-bait tables for both complexes already exist in this repo's own results.json and the question is one correlation away.
  2. The WDR5/WDR50 collision has produced one documented twenty-one-year error in this exact literature and is NOT in data/symbol-collisions.json. Should it be added, and should the IntAct curator note that the sibling entry identified as its highest-leverage output finally be filed? Nobody in this project has ever filed one.
  3. UTP18 is at three baits and was therefore never screened. Extending the source paper's shRNA screen to interactors shared by three or four baits would cover UTP18, UTP14A, RRP9 and FTSJ3 at once and close a never-measured class for four proteins.
Every source behind this entry (5)
  1. E1weak confidence 2 of 5: Preliminary, small, indirect, or not yet peer reviewed.paper

    UTP18 co-purified with three of the seven Strep-HA-tagged MLL fusions in isogenic human Jurkat T-ALL cells - MLL-AF9, MLL-EEN and MLL-ENL - is ABSENT from the MLL-AF4 (= KMT2A::AFF1) column entirely, and at three baits falls below the five-bait threshold of the paper's 128-gene shRNA library so it was never functionally tested against any MLL fusion; the negative control is zero spectra.

    MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. · Skucha A, Ebner J, Schmöllerl J, Roth M, Eder T, César-Razquin A, Stukalov A, Vittori S, Muhar M, Lu B, Aichinger M, Jude J, Müller AC, Győrffy B, Vakoc CR, Valent P, Bennett KL, Zuber J, Superti-Furga G, Grebien F · Nat Commun 2018
    What this evidence cannot show

    THE INDEX FUSION DID NOT RECOVER THIS PROTEIN. UTP18 is absent from the MLL-AF4 column of Supplementary Table 5 entirely -- there is no p-value and no spectral count for it under the index bait. It is an MLL-FUSION interactor, not a demonstrated KMT2A::AFF1 interactor, and nothing in this entry should be read as a KMT2A::AFF1 contact. The 3 baits that did recover it are MLL-AF9, MLL-EEN, MLL-ENL. Negative control: ZERO spectra. THE HEADLINE OF THIS ENTRY: this protein is NOT in the MLL-AF4 column. It is an MLL-FUSION interactor and NOT a demonstrated KMT2A::AFF1 interactor. Six of the eleven nucleolar-block proteins written by this beat are in that position - RRP12, WDR18, UTP14A, RRP9, UTP18 and FTSJ3. The 'thirteen-protein nucleolar block' is a POOLED statement over seven baits; in the index fusion's own column there are seven members and four below p = 0.05. AND IT IS BELOW THE SCREEN THRESHOLD TOO: the source paper's shRNA library covers only the 128 interactors shared by at least five baits, so this protein was never functionally tested against any MLL fusion either. Both records - binding and function - are empty for the index fusion. SCOPING AGAINST THE EXISTING GRAPH ENTRY, which matters more here than anywhere else in this beat: this row is from Skucha 2018 (PMID 29777171), a different paper, bait set, cell line and method from PMID 15199122, whose IntAct curation of a KMT2A-UTP18 association was shown by ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated to be a WDR5 substitution. That finding stands and is NOT weakened by this row; this row is NOT rehabilitated by it. Two independent statements about the same protein. FUNCTIONAL SCREEN -- NOT SCREENED. The shRNA library (MOESM5) covers the 128 interactors shared by at least five of the seven baits: 768 rows, 128 symbols, exactly six shRNAs each, counted with openpyxl by this beat on 2026-09-21. This protein's symbol is NOT in that library, because it falls below the five-bait threshold. So unlike the seven-plus-bait members of this block it has never been functionally tested against any MLL fusion, even in the source paper. That is a stronger absence than measured-not-reported. THE BLOCK, re-measured by this beat on 2026-09-21 by re-running analyses/mll-fusion-interactome-complexes/run.py. A 26-subunit nucleolar / ribosome-biogenesis set returns 15 of 26 present in the 960-protein network against 1.25 expected by chance, hypergeometric p = 6.99e-14, q(BH) = 8.39e-13 across the twelve complexes tested -- the TOP-RANKED complex in the whole interactome, ahead of the CCT/TRiC negative control (q = 1.4e-09) and the SEC positive control (q = 1.5e-09). The fifteen are FBL, FTSJ3, GNL2, LYAR, NOLC1, NOP2, NOP58, PA2G4, RRP12, RRP9, TBL3, TCOF1, UTP14A, UTP18, WDR18. BUT THE BACKGROUND IS THE ~20,000-PROTEIN PROTEOME, not the ~4,600 proteins the study actually recovered before filtering, so every q here is an UPPER BOUND on significance and it is loosest for a complex of abundant nuclear proteins -- which this one is, more than any other row in that table. AND THE POOLED NUMBER IS NOT THE PER-BAIT NUMBER. Subunits of the block recovered per bait, out of 26: MLL-AF1p 8, MLL-AF4 7, MLL-AF9 12, MLL-CBP 10, MLL-EEN 12, MLL-ENL 11, MLL-GAS7 7. The index fusion is TIED LAST. In its column there are seven members and only four at p<0.05 -- GNL2, NOP2, PA2G4 and TBL3; LYAR (0.141), NOLC1 (0.134) and TCOF1 (0.163) are above it. So the strongest complex-level signal in this entire interactome is weakest in the fusion this project studies. SYSTEM: the AP-MS host is JURKAT, a human T-ALL line, while KMT2A::AFF1 disease is B-lineage infant leukaemia; a partner requiring a B-cell or infant proteome cannot appear here and a T-lineage partner can appear spuriously. The bait is a Strep-HA-tagged, SINGLE-COPY, doxycycline-induced transgene at an FRT/Flp cassette, not the endogenous fusion. Prey came from bulk nuclear lysate after a single STREP-Tactin step, so co-purification is NOT evidence of a direct contact. INCLUSION RULE: the paper kept the top 300 interactions per bait by combined p-value rather than applying a p threshold (Methods, verbatim: "All the identified bait-prey pairs were ranked by the combined p-value. The 300 most significant interactions per bait were retained."). In the MLL-AF4 column 186 of 291 listed p-values (63.9%) exceed 0.05; the pooled rate over all baits is 26.6%, and the pooled rate must NOT be quoted for a per-bait claim. BAIT DEPTH: MLL-AF4 is the shallowest of the seven baits by spectral counts, so a low or absent MLL-AF4 count is a property of the bait (transgene expression, purification depth, normalisation) and must not be read as a weaker association. ABUNDANCE IS THE LEADING ALTERNATIVE EXPLANATION. The nucleolus is the densest compartment in the nucleus, every bait here is a tagged nuclear protein, and the complex-level analysis in this repo exists to make exactly that point: its strongest per-bait signature in the index fusion's own column is CCT/TRiC, a canonical AP-MS contaminant, at 8 of 9 subunits with 6 at p<0.05 -- BETTER represented in MLL-AF4's column than the nucleolar block is. Complex-wide enrichment is not by itself evidence of specific binding. THE ARGUMENT ON THE OTHER SIDE: all thirteen members of the nucleolar block, this protein included, have a negative control of ZERO spectra. A non-specific sticky abundant protein would be expected to appear in the control purification too, and none of them does. That is the strongest single fact about this block and it is not explained by abundance alone. SELECTIVITY: the paper's own named NON-selectivity controls are RFC1, SF3A3 and CCT3 -- knockdown inhibited MLL-wild-type K562 and HL-60 as much as MOLM-13 -- against MEN1 as the selective positive. This protein is not among them. That is NOT evidence of selectivity: only 40 of the 128 entered the MLL-r versus MLL-wild-type re-screen and the paper does not say which 40, so absence from the control list is equally consistent with never having reached the second screen. Recorded as UNKNOWN. This entry does not nominate a target. Per-bait membership re-derived by this beat on 2026-09-21 by re-running analyses/skucha-mll-fusion-interactome/run.py (both controls PASS: 128 shared by >=5 baits, 42 by all seven, MEN1 present with all seven) and analyses/mll-fusion-interactome-complexes/run.py. n_fusions and the MLL-AF4 p-value were supplied pre-verified by the coordinator from the cached MOESM4 xlsx and were independently reproduced by this beat's re-run of the complex analysis.

    Evidence that argues against this (3)
    • IntAct has never curated this dataset, so no independent curator has re-examined these calls and no interactome-coverage metric built on IntAct can see them; the raw spectra at ProteomeXchange PXD009338 have not been reanalysed here. The authors themselves removed seven proteins from the shared set by hand as frequently observed contaminants, which concedes that a rank cutoff lets contaminants through. ProteomeXchange/PRIDE 2018
    • The same paper that motivates the nucleolar reading supplies its null hypothesis: MLL-AF4 is reported predominantly nucleolar, so every abundant nucleolar protein becomes a high-probability co-purification partner on compartment grounds alone. And the prediction that reading makes fails -- if nucleolar residency of the bait drove recovery, the index fusion should pull MORE of the block than the other six baits, and it pulls the FEWEST (7 of 26, tied last with MLL-GAS7). The report is also an ectopic-overexpression system, which this project treats as weak evidence about an endogenous protein. Siemund AL et al. 2022
    • The strongest reason for caution about ANY UTP18 row in this literature is that one already turned out to be a curation error that survived twenty-one years and propagated into a 2026 coverage recount in this very project. UTP18's synonym is WDR50, 'WD repeat-containing protein 50', against WDR5, 'WD repeat-containing protein 5' - a collision live in the exact literature this entry belongs to. This beat's row comes from a supplementary table read directly rather than from a curated database, which is why it is not exposed to that specific failure - but the base rate for UTP18 claims in this corpus is one error out of two. IntAct / EMBL-EBI 2026
  2. E2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    Utp18 is an adaptor that recruits the exosome-associated helicase Mtr4 to cleaved rRNA fragments destined for degradation by the exosome, docking through the same consensus motif onto Mtr4's arch domain that Nop53 - the yeast homologue of the tumour suppressor PICT1 - uses to target Mtr4 to pre-ribosomal particles.

    The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins. · Thoms M, Thomson E, Baßler J, Gnädig M, Griesel S, Hurt E · Cell 2015
    What this evidence cannot show

    YEAST plus in vitro reconstitution, 2015 Cell. Not human cells in the arm cited here, not leukaemia, not a fusion. Read from the abstract only. The motif and the arch-domain docking are the abstract's own stated results. Cited because it is the one function in this block that physically connects two of the network's independently enriched complexes - the nucleolar block and NEXT/exosome - and that is a structural observation about the AP-MS network, NOT evidence of anything about a fusion.

    Evidence that argues against this (1)
    • The bridge observation cuts against specificity as hard as it cuts for coherence. Two co-enriched complexes joined by a documented adaptor is the configuration in which one genuine association drags in many passengers, which is precisely how an AP-MS experiment manufactures a coherent-looking non-specific block. The negative control on this repo's own complex table is CCT/TRiC, which is internally coherent at 8 of 9 subunits and is a contaminant. Skucha A et al. 2018
  3. E3moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    UTP18 is a component of the small subunit processome whose only previously known function was cleaving pre-ribosomal RNA to yield 18S rRNA, and it additionally alters translation to promote stress resistance and growth; it is frequently gained and overexpressed in cancer, localises to the cytoplasm in a subset of cells with serum withdrawal increasing cytoplasmic localisation, and cytoplasmic UTP18 associates with the translation complex and Hsp90.

    A small subunit processome protein promotes cancer by altering translation. · Yang HW, Kim TM, Song SS, Menon L, Jiang X, Huang W, Black PM, Park PJ, Carroll RS, Johnson MD · Oncogene 2015
    What this evidence cannot show

    HUMAN cancer cells and copy-number data, 2015 Oncogene. Not leukaemia-specific, not a fusion, not haematopoietic; the cancer-gain analysis is pan-cancer and this beat did not check whether any leukaemia cohort is included. Read from the abstract only. Note the finding that a SUBSET of cells show cytoplasmic UTP18 and that serum withdrawal shifts it - so UTP18's compartment is condition-dependent, which matters for interpreting a nuclear-lysate co-purification from cells in an undefined state.

    Evidence that argues against this (1)
    • A protein 'frequently gained and overexpressed in cancer' is a protein whose abundance is elevated in transformed cells generally - the single most common reason a prey appears in an AP-MS network without binding the bait. For UTP18 specifically this is the second independent abundance argument, alongside its membership of the nucleolus, and it applies to the three baits that recovered it just as much as to the four that did not. Skucha A et al. 2018
  4. E4moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper

    Human GFP-UTP18, with PWP2 and TBL3, localises to the dense fibrillar component and granular component regions of nucleoli - the UTP-B sub-complex distribution - relocates to nucleolar cap and body regions when rRNA transcription is suppressed, and has very low mobility in living cells.

    Dynamics of WD-repeat containing proteins in SSU processome components. · Wada K, Sato M, Araki N, Kumeta M, Hirai Y, Takeyasu K, Furukawa K, Horigome T · Biochem Cell Biol 2014
    What this evidence cannot show

    HUMAN cultured cells, 2014 Biochemistry and Cell Biology; GFP fusions and photobleaching, with the protein set originally defined from a nuclear-matrix fraction. A GFP fusion of a structural nucleolar protein can perturb the assembly it reports on, and 'very low mobility' measures exchange rather than stoichiometry. Not haematopoietic, not a fusion system. Read from the abstract only. This is the ONLY published human sub-nucleolar assignment for UTP18 that this beat found, and it is the same source gene-tbl3 cites for TBL3 - deliberately, so the two entries are consistent; gene-tbl3 was read before this entry was written and was NOT edited.

    Evidence that argues against this (1)
    • If UTP18 is a structurally immobilised nucleolar component with very low exchange, then its recovery from a 420 mM nuclear extract means it was solubilised out of a dense structure, and what co-purifies after that treatment is harder to interpret than a soluble interaction would be. The same objection is recorded in gene-tbl3 against the same source, and it applies to UTP18 identically. Skucha A et al. 2018
  5. E5strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    Separately from and compatibly with the Skucha AP-MS row, IntAct's KMT2A-UTP18 association attributed to PMID 15199122 is a curation error in which UTP18 was substituted for WDR5 - the paper reports eight polypeptides including WDR5 and never mentions UTP18, WDR50 or CGI-48 - and this graph records that adjudication in a dedicated analysis entry which this entry extends and does not revise.

    MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. · Skucha A, Ebner J, Schmöllerl J, Roth M, Eder T, César-Razquin A, Stukalov A, Vittori S, Muhar M, Lu B, Aichinger M, Jude J, Müller AC, Győrffy B, Vakoc CR, Valent P, Bennett KL, Zuber J, Superti-Furga G, Grebien F · Nat Commun 2018
    What this evidence cannot show

    CITATION SCOPE, stated plainly rather than hidden: the adjudication summarised in this claim is the work of the existing graph entry ana-utp18-is-not-in-the-mll-complex-it-is-wdr5-miscurated, which this beat READ IN FULL before writing, and whose primary sources are PMID 15199122 (read there via PMC HTML) and live IntAct MITAB queries. This beat did NOT independently re-run those IntAct queries and did NOT re-read PMID 15199122. The citation attached here is the Skucha paper, which is the source of THIS entry's own row and the reason the scoping note is necessary; it is not the source of the miscuration finding. The miscuration finding is attributed to the sibling entry and should be read there. Recorded this way to avoid re-asserting another entry's primary result as though this beat had verified it.

    Evidence that argues against this (1)
    • The sibling entry's verdict line reads 'no entry written for UTP18 - the partner does not exist'. Read out of context that could be taken to mean UTP18 has no relationship to MLL fusions at all, which the Skucha table contradicts at three of seven baits. The two are compatible - the verdict is scoped to the IntAct/PMID 15199122 row - but the wording is quotable in a misleading way, and this beat reports that to the coordinator as a clarification owed on an entry it does not own, NOT as an error. IntAct / EMBL-EBI 2026
Connected to